Pharmacokinetics and Pharmacodynamics of High-Dose PiperacillinTazobactam in Obese Patients

JJ Veillette, SA Winans, VK Maskiewicz… - … and Pharmacokinetics, 2021 - Springer
… –139 kg or ≥ 140 kg were given up to 6.75 g or 9 g every … piperacillin steady-state
trough concentrations for the same patients on two different dosing regimens: Piperacillintazobactam

Population pharmacokinetics of continuous infusion of piperacillin/tazobactam in very elderly hospitalized patients and considerations for target attainment against …

PG Cojutti, E Morandin, M Baraldo, F Pea - International journal of …, 2021 - Elsevier
pharmacokinetic analysis of CI piperacillin/tazobactam, and to … steady-state concentration
(Css) of increasing piperacillin/… PIP is typically co-administered with tazobactam (TAZ), a beta-…

[PDF][PDF] Clinical Pharmacology of Piperacillin/Tazobactam

GM Pacifici - J Clin Biomed Invest, 2023 - respubjournals.com
… intravenously at a dose of 500 mg/500 mg/250 mg 4 times-daily [35], and piperacillin/
tazobactam administered by continuous infusion at a dose of 4.5/0.5 grams 4 times-daily effectively …

Piperacillin-tazobactam in intensive care units: a review of population pharmacokinetic analyses

I El-Haffaf, JA Caissy, A Marsot - Clinical pharmacokinetics, 2021 - Springer
administration to achieve appropriate pharmacodynamic targets. This review synthesizes
important pharmacokinetic elements for piperacillin-tazobactam … s pharmacokinetic parameters …

An integral pharmacokinetic analysis of piperacillin and tazobactam in plasma and urine in critically ill patients

E Wallenburg, R Ter Heine, JA Schouten… - … pharmacokinetics, 2022 - Springer
… It is strongly recommended to administer piperacillintazobactam as a prolonged (ie
continuous or … Total piperacillin and tazobactam concentrations were predicted at steady-state. …

Population pharmacokinetics of piperacillin/tazobactam across the adult lifespan

M Hemmersbach-Miller, SJ Balevic, PL Winokur… - … pharmacokinetics, 2023 - Springer
… interval at steady state (50% fT >MIC ); (2) unbound piperacillin concentrations above the …
physiology and pathophysiology was considered, given the sparse sampling in this study. The …

A population pharmacokinetics and pharmacodynamic approach to optimize tazobactam activity in critically ill patients

SN Kalaria, M Gopalakrishnan… - Antimicrobial agents and …, 2020 - Am Soc Microbiol
… was at steady state (at least 4 doses of TZP had been given). The serum creatinine level
was measured with morning clinical labs during the day of pharmacokinetic sampling and was …

… of Different Piperacillin-Tazobactam Dosage Regimens on Synergy of the Combination with Tobramycin against Pseudomonas aeruginosa for the Pharmacokinetics …

JR Tait, H Bilal, KE Rogers, Y Lang, TH Kim, J Zhou… - Antibiotics, 2022 - mdpi.com
piperacillin-tazobactam administered via intermittent infusions in combination with tobramycin
was synergistic against a piperacillin… to achieve the steady-state trough concentration at 0 …

Comparing clinical outcomes of piperacillin-tazobactam administration and dosage strategies in critically ill adult patients: a systematic review and meta-analysis

S Fawaz, S Barton, S Nabhani-Gebara - BMC Infectious Diseases, 2020 - Springer
administration of piperacillin-tazobactam has been proposed as a valuable alternative to
traditional intermittent administration … outcomes of piperacillin tazobactam dosing regimens, …

Could an Optimized Joint Pharmacokinetic/Pharmacodynamic Target Attainment of Continuous Infusion Piperacillin-Tazobactam Be a Valuable Innovative Approach …

M Gatti, M Rinaldi, T Tonetti, A Siniscalchi, P Viale… - Antibiotics, 2023 - mdpi.com
Piperacillin-tazobactam was administered at a median (IQR) daily … for optimizing CI
piperacillin-tazobactam exposure were … Median (IQR) piperacillin and tazobactam free …